E2 transdermal (Julina, BAY86-5435)

DRUG2 trials

Sponsors

Bayer

Conditions

Osteoporosis, Postmenopausal

Unknown Phase

Julina Post-marketing Surveillance for Climacteric Symptoms in Japan

CompletedNCT01386281

BayerOsteoporosis, Postmenopausal

Start: 2008-10-20End: 2014-04-15Updated: 2018-04-17

Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan

CompletedNCT01397955

BayerOsteoporosis, Postmenopausal

Start: 2009-01-31End: 2014-04-30Updated: 2015-04-17